STAGE IIIC LUNG CANCER AJCC V8
Clinical trials for STAGE IIIC LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIC LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to reboot immune attack on tough cancers
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could s…
Matched conditions: STAGE IIIC LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 02:39 UTC
-
Cancer cocktail trial halted: immunotherapy plus radiation shows promise but stops short
Disease control TerminatedThis early-stage trial tested a combination of two immunotherapy drugs (BMS-986218 and nivolumab) plus precise, high-dose radiation in 13 people with advanced solid tumors that had spread. The goal was to see if this mix could help the immune system attack cancer more effectively…
Matched conditions: STAGE IIIC LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 02:39 UTC